Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Researchers at Oregon Health & Science University have identified a gene that plays a crucial role in the brain's ability to ...

Discovery may open the way for new treatments for multiple sclerosis, leukodystrophies OHSU researchers discover a gene that ...

For people with fluctuating and often invisible conditions such as multiple sclerosis (MS), welfare and work are not opposed.

On World Brain Day 2025, let us know why migraine, ADHD and early multiple sclerosis are quietly rising in young adults. In ...